azathioprine has been researched along with Hyperglycemia in 15 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF." | 9.10 | Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. ( Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M, 2003) |
| "Two hundred twenty-three recipients of first cadaveric kidney allografts were randomized to receive tacrolimus (TAC) + mycophenolate mofetil (MMF), TAC + azathioprine (AZA), or cyclosporine (Neoral; CsA) + MMF." | 5.10 | Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. ( Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M, 2003) |
| " Is the evidence now sufficient to support the routine use of regimens including CNIs in LN? Although CNIs appear to have similar efficacy to MMF-based regimens as induction therapy, and are comparable with azathioprine as maintenance treatment, CNI toxicities, such as new-onset hypertension, hyperglycaemia and nephrotoxicity, have been problematic." | 3.83 | Con: The use of calcineurin inhibitors in the treatment of lupus nephritis. ( Fernandez Nieto, M; Jayne, DR, 2016) |
| "Post-transplant diabetes mellitus is a significant risk factor for cardiovascular disease in solid organ transplantation." | 2.52 | Immunosuppression and Post-transplant Hyperglycemia. ( Montero, N; Pascual, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montero, N | 1 |
| Pascual, J | 1 |
| Fernandez Nieto, M | 1 |
| Jayne, DR | 1 |
| Gonwa, T | 1 |
| Johnson, C | 1 |
| Ahsan, N | 1 |
| Alfrey, EJ | 1 |
| Halloran, P | 1 |
| Stegall, M | 1 |
| Hardy, M | 1 |
| Metzger, R | 1 |
| Shield, C | 1 |
| Rocher, L | 1 |
| Scandling, J | 1 |
| Sorensen, J | 1 |
| Mulloy, L | 1 |
| Light, J | 1 |
| Corwin, C | 1 |
| Danovitch, G | 1 |
| Wachs, M | 1 |
| VanVeldhuisen, P | 1 |
| Leonhardt, M | 1 |
| Fitzsimmons, WE | 1 |
| RIFKIND, D | 1 |
| MARCHIORO, TL | 1 |
| WADDELL, WR | 1 |
| STARZL, TE | 1 |
| Paterson, AJ | 1 |
| Lamey, PJ | 1 |
| Lewis, MA | 1 |
| Nolan, A | 1 |
| Rademaker, M | 1 |
| Walker, RE | 1 |
| McCrindle, BW | 1 |
| Coles, JG | 1 |
| West, LJ | 1 |
| Roth, D | 1 |
| Milgrom, M | 1 |
| Esquenazi, V | 1 |
| Fuller, L | 1 |
| Burke, G | 1 |
| Miller, J | 1 |
| Amiel, JA | 1 |
| Toledo-Pereyra, LH | 1 |
| Hill, CM | 1 |
| Douglas, JF | 1 |
| Rajkumar, KV | 1 |
| McEvoy, J | 1 |
| McGeown, MG | 1 |
| Zimmermann, G | 1 |
| Hell, E | 1 |
| Anderson, RJ | 1 |
| Schafer, LA | 1 |
| Olin, DB | 1 |
| Eickhoff, TC | 1 |
| Gliedman, ML | 1 |
| Gold, M | 1 |
| Whittaker, J | 1 |
| Rifkin, H | 1 |
| Soberman, R | 1 |
| Freed, S | 1 |
| Tellis, V | 1 |
| Veith, FJ | 1 |
| Inou, T | 2 |
| Ota, K | 2 |
| Mori, S | 2 |
| Reemtsma, K | 1 |
| Giraldo, N | 1 |
| Depp, DA | 1 |
| Eichwald, EJ | 1 |
| Kanazawa, Y | 1 |
| Kuzuya, T | 1 |
1 review available for azathioprine and Hyperglycemia
| Article | Year |
|---|---|
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Ever | 2015 |
1 trial available for azathioprine and Hyperglycemia
| Article | Year |
|---|---|
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; | 2003 |
13 other studies available for azathioprine and Hyperglycemia
| Article | Year |
|---|---|
Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Hyperglycemia; Hyperte | 2016 |
INFECTIOUS DISEASES ASSOCIATED WITH RENAL HOMOTRANSPLANTATION.
Topics: Adolescent; Agammaglobulinemia; Agranulocytosis; Azathioprine; Bacteriophage Typing; Child; Diagnosi | 1964 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; | 1998 |
Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
Topics: Actuarial Analysis; Adult; Azathioprine; Cyclosporins; Diabetes Mellitus; Female; Graft Survival; Hu | 1989 |
[Transplantation of pancreatic islets in dogs--a new method].
Topics: Animals; Azathioprine; Dogs; Hyperglycemia; Immunosuppression Therapy; Islets of Langerhans Transpla | 1986 |
Glycosuria and hyperglycaemia after kidney transplantation.
Topics: Acute Disease; Azathioprine; Glucose Tolerance Test; Glycosuria; Humans; Hydrocortisone; Hyperglycem | 1974 |
[Transplantation and preservation by freezing of the pancreas in dogs].
Topics: Amylases; Animals; Azathioprine; Dogs; Female; Freezing; Glucose Tolerance Test; Graft Rejection; Gr | 1971 |
Infectious risk factors in the immunosuppressed host.
Topics: Adolescent; Adult; Agammaglobulinemia; Age Factors; Antilymphocyte Serum; Azathioprine; Child; Femal | 1973 |
Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage.
Topics: Adult; Azathioprine; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Humans; Hyperglycemi | 1973 |
Manifestations of rejection of pancreaticoduodenal allografts.
Topics: Amylases; Animals; Azathioprine; Blood Glucose; Dogs; Duodenum; Histocompatibility; Hyperglycemia; I | 1968 |
Islet cell transplantation.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Female; Hyperglycemia; Male; Mercaptopurine; Pancreas; P | 1968 |
Endocrine function of the pancreatic allograft.
Topics: Animals; Azathioprine; Blood Glucose; Dogs; Glucose Tolerance Test; Graft vs Host Disease; Hyperglyc | 1968 |